Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 25, 2026
MOV vs SIG: Movado's +70% 52-Week Surge Compared to Signet's Modest Gains

MOV vs SIG: Movado's +70% 52-Week Surge Compared to Signet's Modest Gains

Key Takeaways

  • MOV (Movado Group) and SIG (Signet Jewelers) both operate in consumer discretionary retail, yet differ sharply in scale, category exposure, and valuation.
  • Signet is the far larger business, with roughly $6.8 billion in trailing revenue, versus about $690 million for Movado.
  • Movado has shown stronger recent price momentum, up substantially over the past 52 weeks, while Signet's one-year gain has been more modest.
  • Signet trades at a notably lower earnings multiple and has been raising guidance, supported by positive comparable sales and a large new credit agreement.
  • Movado carries a higher dividend yield and a stronger net-cash balance sheet, while Signet offers greater scale, diversification, and institutional coverage.
  • Relative performance and risk profiles diverge: Movado is a smaller, higher-yielding turnaround story, whereas Signet is a larger, more diversified retailer.

Introduction

When weighing exposure to discretionary spending on watches and jewelry, investors comparing MOV and SIG are essentially choosing between two distinct approaches. Movado Group focuses on watch design and distribution, while Signet Jewelers stands as one of the world's largest specialty jewelry retailers with brands such as Kay, Zales, and Jared. This comparison matters for traders tracking relative performance and momentum, as well as longer-term investors assessing growth drivers, balance-sheet strength, and positioning amid tariffs, gold prices, and shifting demand. I also checked this using Tickeron’s AI Screener to see how the stocks compare to others in the industry.

Movado Group's Recent Momentum

Movado Group (MOV) designs, manufactures, and distributes watches across owned and licensed fashion brands. The company has a modest market capitalization of roughly $745 million and reported trailing twelve-month revenue of about $690 million. In recent weeks, Movado's stock has reflected a meaningful recovery, with a 52-week gain exceeding 70% and a solid year-to-date advance, even after pulling back from recent highs.

The company's most recent quarterly results beat Wall Street expectations on both earnings and revenue, with net sales up approximately 5% year over year and earnings per share well above consensus. Management pointed to product innovation and pricing actions as contributors to margin support. Movado also pays a substantial dividend, currently yielding near 4.8%, and maintains a conservative balance sheet with a large net cash position relative to its modest debt. Sentiment has been supported by improving fundamentals, though the stock remains well below the average analyst price target from a small pool of coverage. From what I see, the clean balance sheet stands out here.

Signet Jewelers' Scale and Catalysts

Signet Jewelers (SIG) is a leading specialty jewelry retailer operating across North America and the United Kingdom through brands including Kay, Zales, Jared, Banter, and Blue Nile. With trailing revenue of roughly $6.8 billion and a market capitalization near $3.85 billion, it is a substantially larger and more diversified enterprise than Movado. In recent market activity, Signet shares have traded near the $100 level, with a more muted one-year return than Movado but a solid year-to-date gain.

Signet's recent quarter featured earnings that surpassed estimates by a wide margin, while same-store sales rose modestly, marking its fifth positive comparable-sales quarter in six. The company raised its full-year guidance and highlighted a new consumer credit partnership expected to deliver significant incremental operating benefit over the coming years. Signet also expanded its share repurchase authorization. Key watch points include tariff headwinds, gold-price volatility, and softness in lower-priced fashion jewelry, which management continues to navigate. I’m watching this closely for how the credit agreement plays out.

Comparing the Two Side by Side

The most immediate contrast between these two stocks is scale and category focus. Signet (SIG) is a diversified, multi-brand jewelry retailer with an international footprint, while Movado (MOV) is a more concentrated watch specialist dependent on owned and licensed brands. This concentration gives Movado a cleaner, asset-light profile but also exposes it to brand-license renewal risk and narrower demand trends.

On valuation, Signet trades at a considerably lower earnings multiple and a lower price-to-sales ratio, reflecting its larger earnings base and more cautious market sentiment around jewelry retail. Movado commands a higher multiple and a richer dividend yield, supported by a stronger net-cash balance sheet and lower beta, which may appeal to income-oriented investors. In contrast, Signet carries more leverage but generates greater absolute free cash flow and has been actively returning capital through buybacks.

Momentum also differs. Movado's relative performance has been stronger over the trailing year, while Signet's gains have been steadier but less pronounced. Risk profiles diverge as well: Movado faces concentration and licensing risks, whereas Signet faces tariff exposure, gold-cost pressure, and dependence on holiday-season execution.

An AI-Informed Perspective

Based on observable factors, an AI-driven view would likely lean toward MOV for relative momentum and trend consistency, given its stronger recent price trajectory, higher yield, and clean balance sheet. However, on valuation, scale, and the presence of multiple recent positive catalysts—including raised guidance and a large credit agreement—SIG presents a more diversified and fundamentally supported profile. The probability-weighted view therefore favors Signet for stability and fundamentals, while Movado may appeal to momentum- and income-oriented strategies. Neither outcome is guaranteed, and relative positioning could shift quickly with the next earnings report or consumer-demand signal.

Using Tickeron AI Trading Bots for Deeper Insights

In my research process, I often turn to Tickeron’s platform when evaluating names like these. The AI Trading Bots offer a range of automated strategies that monitor market conditions across different timeframes and risk levels, helping me cross-check momentum signals and relative performance without manual charting every step of the way. This adds a systematic layer to the fundamental comparison above.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MOV, SIG

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


MOV's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for MOV turned positive on September 15, 2026. Looking at past instances where MOV's MACD turned positive, the stock continued to rise in 32 of 47 cases over the following month. The odds of a continued upward trend are 68%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MOV's RSI Indicator exited the oversold zone, 14 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 56%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 43 of 64 cases where MOV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.

The Momentum Indicator moved above the 0 level on September 22, 2026. You may want to consider a long position or call options on MOV as a result. In 61 of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.

Following a +1.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where MOV advanced for three days, in 176 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

MOV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MOV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.

The Aroon Indicator for MOV entered a downward trend on September 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.475) is normal, around the industry mean (6.438). P/E Ratio (18.464) is within average values for comparable stocks, (16.976). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (0.390). Dividend Yield (0.045) settles around the average of (0.035) among similar stocks. P/S Ratio (1.090) is also within normal values, averaging (1.399).

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. MOV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 74 (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 76 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 80 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MOV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.

Notable companies

The most notable companies in this group are Signet Jewelers Limited (NYSE:SIG), Capri Holdings Limited (NYSE:CPRI), RealReal (The) (NASDAQ:REAL).

Industry description

The catalog and specialty distribution industry includes companies that offer retail through mail-order houses, media, online social platforms, mobile apps and other channels outside of brick-and-mortar stores. Several companies in this business partner with retail companies to assist them with marketing, digital solutions, warehousing, and/or other distribution capabilities. In essence, the industry acts as a potential catalyst for retailers/brands to widen their reach among customers. Pinduoduo Inc., Qurate Retail, Inc. and Baozun are some of the major players in this business.

Market Cap

The average market capitalization across the Catalog/Specialty Distribution Industry is 3.13B. The market cap for tickers in the group ranges from 120.92K to 222.8B. LVMUY holds the highest valuation in this group at 222.8B. The lowest valued company is SSOK at 120.92K.

High and low price notable news

The average weekly price growth across all stocks in the Catalog/Specialty Distribution Industry was -2%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 3%. CPRI experienced the highest price growth at 2%, while ELA experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Catalog/Specialty Distribution Industry was -9%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was 5%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 38
P/E Growth Rating: 81
Price Growth Rating: 54
SMR Rating: 66
Profit Risk Rating: 84
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
MOV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of watches

Industry CatalogSpecialtyDistribution

Industry
Other Consumer Specialties
Address
650 From Road
Phone
+1 201 267-8000
Employees
272
Web
https://www.movadogroup.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.
MOV vs SIG: Movado's +70% 52-Week Surge Compared to Signet's Modest Gains